Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System

thumbnail.default.alt
Data
2015
Autores
Pinto, Márcia
Entringer, Aline Piovezan
Steffen, Ricardo
Trajman, Anete
Journal Title
Journal ISSN
Volume Title
Publisher
Jornal Brasileiro de Pneumologia
Resumo
We estimated the costs of a molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) and of smear microscopy, within the Brazilian Sistema Único de Saúde (SUS, Unified Health Care System). In SUS laboratories in the cities of Rio de Janeiro and Manaus, we performed activity-based costing and micro-costing. The mean unit costs for Xpert MTB/RIF and smear microscopy were R$35.57 and R$14.16, respectively. The major cost drivers for Xpert MTB/RIF and smear microscopy were consumables/reagents and staff, respectively. These results might facilitate future cost- effectiveness studies and inform the decision-making process regarding the expansion of Xpert MTB/RIF use in Brazil.
Description
Palavras-chave
Costs and cost analysis, Tuberculosis, Nucleic acid amplification techniques
Citação
Pinto M, Entringer AP, Steffen R, Trajman A. Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System. J Bras Pneumol. 2015 Nov-Dec;41(6):536-8. doi: 10.1590/S1806-37562015000004524. Erratum in: J Bras Pneumol. 2016 Jan-Feb;42(1):79. doi: 10.1590/S1806-37562016000004524errata.